Adlai Nortye (ANL) Other Gross PP&E Adjustments (2022 - 2025)
Adlai Nortye (ANL) reported Other Gross PP&E Adjustments of $5.7 million for Q4 2025, up 28.38% year-over-year from $4.4 million in Q4 2024, and up 991.82% on a QoQ basis from -$636000.0 in Q2 2025.
Adlai Nortye (ANL) has 4 years of Other Gross PP&E Adjustments data on file, last reported at $5.7 million in Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 28.38% year-over-year to $5.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.7 million (up 28.38% YoY) and the FY2025 annual result came in at $5.7 million, up 28.38% from the prior year.
- Other Gross PP&E Adjustments advanced to $5.7 million in Q4 2025 per ANL's latest filing, from -$636000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $6.5 million in Q4 2022 and bottomed at -$678000.0 in Q2 2024.
- The 4-year median for Other Gross PP&E Adjustments is $4.9 million (2023), against an average of $3.5 million.
- The widest annual swing landed in 2024, when Other Gross PP&E Adjustments dropped 18.73%; it then rose 28.38% in 2025.
- Tracing ANL's Other Gross PP&E Adjustments over 4 years: stood at $6.5 million in 2022, then fell by 16.92% to $5.4 million in 2023, then retreated by 18.73% to $4.4 million in 2024, then gained by 28.38% to $5.7 million in 2025.
- Per Business Quant, the three latest ANL Other Gross PP&E Adjustments figures stand at $5.7 million (Q4 2025), -$636000.0 (Q2 2025), and $4.4 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | 5.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.67 Mn |
| Dec 31, 2025 | 5.67 Mn |
| Jun 30, 2025 | -636,000.00 |
| Jun 30, 2025 | -636,000.00 |
| Dec 31, 2024 | 4.42 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Jun 30, 2024 | -678,000.00 |
| Jun 30, 2024 | -678,000.00 |
| Dec 31, 2023 | 5.44 Mn |
| Dec 31, 2023 | 5.44 Mn |
| Dec 31, 2022 | 6.54 Mn |
| Dec 31, 2022 | 6.54 Mn |